Abstract:Editorial Office Annals of Translational Medicine Submitted Jul 21, 2024. Accepted for publication Aug 02, 2024. Published online Sep 05, 2024. doi: 10.21037/atm-2024-9 Erratum to: Ann Transl Med 2021;9:533 The article (1) titled "ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway" (doi: 10.21037/atm-20-7005), unfortunately contains several errors that need to be corrected. The image in the upper right corner of Figure 2F, which represents the migration of the control shRNA-expressing MDA-MB-231 cells, was selected incorrectly. This image should be replaced with the correct one. In the legend of Figure 2, the order of the parts corresponding to Figure 2E-2I was incorrect. The correct order is: (E) colony formation assay on MDA-MB-231; (F) migration assay on MDA-MB-231; (G) migration assay on MDA-MB-468; (H) invasion assay on MDA-MB-231; (I) invasion assay on MDA-MB-468. The caption "MDA-MB-468" in Figure 4 was accidentally misplaced between Figure 4D and Figure 4F, which should be at the bottom of Figure 4C . In the legend of Figure 4, the order of the parts corresponding to Figure 4C-4F was incorrect. The correct order is: (C) CCK-8 assay on MDA-MB-468; (D) migration assay on MDA-MB-231; (E) migration assay on MDA-MB-468; (F) invasion assay on MDA-MB-231. Figure 2F in the original article: The legend of Figure 2 in the original article: Caption "MDA-MB-468" in Figure 4 in the original article: The legend of Figure 4 in the original article: The updated version of Figure 2 , containing the correct image for the "Control" in Figure 2F , and the updated version of Figure 4 with the correct position of the caption "MDA-MB-468", together with the correct legends for both figures, are shown below. These errors did not significantly affect either the results or the conclusions of the paper. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Erratum: Correction: Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway (The Journal of biological chemistry (2019) 294 17 (7037-7045))

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Erratum: the PI 3-Kinase/akt Signaling Pathway is Activated Due to Aberrant Pten Expression and Targets Transcription Factors NF-κB and C-Myc in Pancreatic Cancer Cells

Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway: Erratum

Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Erratum to "Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation"

Correction: Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

[Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway

[Corrigendum] PRIMA‐1 met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‐ULK1‐Vps34 signaling cascade

[Corrigendum] Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.

[Corrigendum] Role of 4‑aminobutyrate Aminotransferase (ABAT) and the Lncrna Co‑expression Network in the Development of Myelodysplastic Syndrome

Erratum: The pleiotropic roles of sphingolipid signaling in autophagy

Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression

Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3